Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Gpb Scientific LLC is active in the Biotechnology & Pharmaceuticals technology area. The portfolio currently has 1 pending office action, which is being handled by 1 distinct examiner. This reflects 1 point of engagement with the patent office for their current scientific instrument applications.
The examination process is limited to 1 distinct art unit. OLSON, ALEXANDRA NADINE is the busiest examiner for the portfolio, responsible for 1 busiest examiner pending office action. This 1 pending action represents the full extent of the company's current prosecution workload. Because there is only 1 distinct examiner and 1 distinct art unit, the prosecution strategy is highly focused. The 1 pending office action is the only current barrier to potential allowance in the Biotechnology & Pharmaceuticals area. Practitioners must manage this 1 relationship with the examiner to advance the portfolio and ensure the company's scientific innovations are protected.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| OLSON, ALEXANDRA NADINE | 1 | 100.0% | +0.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18310098 | FETAL ANEUPLOIDY DETECTION BY SEQUENCING | OLSON, ALEXANDRA NADINE | 7d |
| Art Unit | Apps |
|---|---|
| 1684 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18310098 | FETAL ANEUPLOIDY DETECTION BY SEQUENCING | OLSON, ALEXANDRA NADINE | 1684 | §103Other | Final Rejection | 7d | Pending | May 01, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial